Antiplatelet Therapy and Cardiovascular Diseases

37 та иш

Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures
E. Shalaeva, Hugo Saner, B. Janabaev +1
МақолаAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Preventive Cardiology20173 иқтибос
ABI
Polyelectrolyte Microcapsules—A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release
Aleksandr L. Kim, Egor V. Musin, M. Zh. Oripova +3
МақолаAtrial Fibrillation Management and OutcomesInternational Journal of Molecular Sciences20231 иқтибос
ABI
QANDLI DIABET KASALLIGI FONIDA YURAK QON TOMIR TIZIMI KASALLIKLARINING KLINIK KECHUV XUSUSIYATLARI
Исламова Камола Акрамовна, Карабаева Гульчехра Худойбердиевна
МақолаDiabetes, Cardiovascular Risks, and Lipoproteins20201 иқтибос
ABI
Resveratrol Inhibits Platelet Aggregation in Aspirin Resistance
Gyorgyi Stef, Kenneth M. Lerea, Joseph Wu +2
МақолаAntiplatelet Therapy and Cardiovascular DiseasesThe FASEB Journal20060 иқтибос
ABI
Polysthicol
Shakhnoza S. Azimova
БобCase Reports on Hematomas20120 иқтибос
ABI
Methylquadrangularate C
Shakhnoza S. Azimova
БобCancer Treatment and Pharmacology20120 иқтибос
ABI
Influence of Lipid Transport System Gene Polymorphism on the Dyslipidemia and Coronary Lesions in Patients with Unstable Angina
A. S. Eshpulatov, Tashkent, Uzbekistan, Shavkat Hashimov +2
МақолаLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20150 иқтибос
ABI
One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
Nabijon Yuldashev, Robert Gil, R. D. Kurbanov
МақолаCoronary Interventions and DiagnosticsInternational Journal of Biomedicine20180 иқтибос
ABI
PO149 Compliance of Patients With Coronary Artery Disease In Correlation With Clinical and Angiographic Data
G. Nagaeva, N. Juldashev, S. Nagaev
МақолаPeripheral Artery Disease ManagementGlobal Heart20180 иқтибос
ABI
Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms
Jamol Uzokov, B. A. Alyavi
МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20200 иқтибос
ABI
Prevalence and Features of Aspirin Resistance in Patients with Coronary Artery Disease
Khodjanova SH
МақолаAntiplatelet Therapy and Cardiovascular DiseasesCross Current International Journal of Medical and Biosciences20200 иқтибос
ABI
Evaluations of Hemostatic Activity of Ethanol Extract of Euonymus fortunei Aerial Parts
Xi‐Lin Ouyang, Lin-Yan Shu, Xiaoya Qin +1
МақолаPlatelet Disorders and TreatmentsJournal of Pharmaceutical Research International20210 иқтибос
ABI
Aspirin Resistance in Patients with Chronic Coronary Syndrome
A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1
МақолаAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology20210 иқтибос
ABI
Antiplatelet therapy with clopidogrel taking into account CYP2C19 genetic polymorphisms in patients with coronary heart disease after coronary artery stenting
Jamol Uzokov, B. A. Alyavi, A. Abdullaev +2
МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20210 иқтибос
ABI
ANTIPLATELET THERAPY AND SECONDARY PROPHYLAXIS AFTER CORONARY BYPASS SURGERY IN ACUTE CORONARY SYNDROME
Jalilov A.K., Isadora Almeida G
МақолаAntiplatelet Therapy and Cardiovascular DiseasesMedical & pharmaceutical journal Pulse20210 иқтибос
ABI
The value of the Left Ventricular Emission Fraction in Patients with Ischaemic Heart Disease with Diabetes Mellitus 2 in the Assessment of the Effectiveness of Sitagliptin/Metformin
Раиса Тригулова, Dilnoza Alimova, N.F. Tashkenbaeva +4
МақолаDiabetes Treatment and ManagementAmerican Heart Journal20210 иқтибос
ABI
YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA ATSETILSALITSIL KISLOTANING ANTIAGREGANT VA YALLIG'LANISHGA QARSHI XUSUSIYATLARI
Шахноза Искандаровна Ходжанова
МақолаAntiplatelet Therapy and Cardiovascular Diseases20210 иқтибос
ABI
Advantages of aspirin in the prevention of cardiovascular disease
M Niladri, Gayatri Devi, Prateek Porwal +4
МақолаInflammatory mediators and NSAID effectsInternational Journal of Health Sciences20220 иқтибос
ABI
Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD
Р Алиева, A. Eshpulatov, Aleksandr B. Shek
МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20220 иқтибос
ABI
Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease
Jamol Uzokov, B. Alyavi, A. Kh. Abdullaev +2
МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20220 иқтибос
ABI
#4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD
Yorkin Rasulev, Durdona Adylova
МақолаPeripheral Artery Disease ManagementNephrology Dialysis Transplantation20230 иқтибос
ABI
Ticagrelor in the treatment of patients with acute coronary syndrome: own clinical experience
Н Юлдошев, Г. А. Нагаева, М. Ж. Журалиев +3
МақолаAntiplatelet Therapy and Cardiovascular DiseasesThe Bulletin of Emergency Medicine20230 иқтибос
ABI
Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions
M Mukhamedova, D Z Orziev, Jamol Uzokov +1
МақолаAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Cardiovascular Nursing20230 иқтибос
ABI
Relationship between blood inflammation state and platelet aggregation rate in patients with atherosclerotic coronary artery disease after percutaneous coronary interventions
Jamol Uzokov, Bakhromkhon Alyavi, B. Karimov +1
МақолаInflammatory Biomarkers in Disease PrognosisAtherosclerosis20230 иқтибос
ABI
CHANGES IN THE LEVEL OF C-REACTIVE PROTEIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHILE TAKING COLCHICINE
Agababyan Irina Rubenovna, KOBILOVA Nigina Akmalovna
МақолаLipoproteins and Cardiovascular HealthZenodo (CERN European Organization for Nuclear Research)20230 иқтибос
ABI